# A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children

> **NCT01458418** · NA · TERMINATED · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 4 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Montelukast
- **OTHER:** placebo
- **DRUG:** 5 mg Montelukast

## Key facts

- **NCT ID:** NCT01458418
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Inability to complete enrollment due to difficulty in finding subjects
- **Last updated:** 2020-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458418, "A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01458418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*